Clinical trial
Quality of Life (QOL) in Female Patient With Schizophrenia
NCT00498004 · Inje University, Other · Terminated
Key facts
| NCT number | NCT00498004 |
|---|---|
| Title | Quality of Life (QOL) in Female Patient With Schizophrenia |
| Official title | Randomized, Open Label, 8-Week Study of Quetiapine and Risperidone on Quality of Life in Female With Schizophrenia |
| Lead sponsor | Inje University, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Quetiapine, Risperidone |
| Enrollment | 100 |
| Start date | Aug 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jul 9, 2007 |
| Last update posted | Nov 4, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: